SARS-CoV-2 Infection in Pregnant Women and Their Newborns

There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Melanie Etti, Musa Sekikubo, Victoria Nankabirwa, Halvor Sommerfelt, Bridget Freyne, Kondwani Kawaza, Gladys Gadama, Kondwani Jambo, Esperança Sevene, Marleen Temmerman, Laura A. Magee, Peter von Dadelszen, Asma Khalil, Kirsty Le Doare, WHO/HRP Alliance author group
Formato: article
Lenguaje:EN
Publicado: Ubiquity Press 2020
Materias:
Acceso en línea:https://doaj.org/article/16cd9404b5ce401bb3e6574b680a6333
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harnessing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.